Forensic Science International
Volume 159, Issue 2 , Pages 83-91 , 2 June 2006

Flunitrazepam: Psychomotor impairment, agitation and paradoxical reactions

  • Jørgen G. Bramness

      Affiliations

    • Norwegian Institute of Public Health, Department of Pharmacoepidemiology, PO Box 4404, Nydalen, NO-0403 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 23407800.
    • ,
  • Svetlana Skurtveit

      Affiliations

    • Norwegian Institute of Public Health, Department of Pharmacoepidemiology, PO Box 4404, Nydalen, NO-0403 Oslo, Norway
    • ,
  • Jørg Mørland

      Affiliations

    • Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, PO Box 4404, Nydalen, NO-0403 Oslo, Norway

Received 14 April 2005 ,Revised 20 June 2005 ,Accepted 25 June 2005.

References 

  1. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994;48:25–40
  2. Gottesmann C. GABA mechanisms and sleep. Neuroscience. 2002;111:231–239
  3. Ballenger JC. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J. Clin. Psychiatry. 2001;62:11–19
  4. Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42:8–12
  5. Mancuso C, Tanzi M, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004;24:1177–1185
  6. Cole J, Kando J. Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. J. Clin. Psychiatry. 1993;54:49–61
  7. Hall RC, Zisook S. Paradoxical reactions to benzodiazepines. Br. J. Clin. Pharmacol. 1981;11:99S–104S
  8. Paton P. Benzodiazepines and disinhibition. Psychiatr. Bull. 2002;26:460–462
  9. Fulton SA, Mullen KD. Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil?. Am. J. Gastroenterol. 2000;95:809–811
  10. Bond AJ, Lader MH, da Silveira JCC. Aggression, individual differences, alcohol and benzodiazepines. Maudsley Monographs. London: Psychology Press; 1997;
  11. Cherek DR, Spiga R, Roache JD, Cowan KA. Effects of triazolam on human aggressive, escape and point-maintained responding. Pharmacol. Biochem. Behav. 1991;40:835–839
  12. Salzman C, Kochansky GE, Shader RI, Harmatz JS, Ogletree AM, Gardos G, et al. Is oxazepam associated with hostility? Differential actions of chlordiazepoxide and oxazepam on hostility. Dis. Nerv. Syst. 1975;36:30–32
  13. Kochansky GE, Salzman C, Shader RI, Harmatz JS, Ogeltree AM. The differential effects of chlordiazepoxide and oxazepam on hostility in a small group setting. Am. J. Psychiatry. 1975;132:861–863
  14. Daderman AM, Fredriksson B, Kristiansson M, Nilsson LH, Lidberg L. Violent behavior, impulsive decision-making, and anterograde amnesia while intoxicated with flunitrazepam and alcohol or other drugs: a case study in forensic psychiatric patients. J. Am. Acad. Psychiatr. Law. 2002;30:238–251
  15. Daderman AM, Edman G. Flunitrazepam abuse and personality characteristics in male forensic psychiatric patients. Psychiatr. Res. 2001;103:27–42
  16. Daderman AM, Lidberg L. Flunitrazepam (Rohypnol) abuse in combination with alcohol causes premeditated, grievous violence in male juvenile offenders. J. Am. Acad. Psychiatr. Law. 1999;27:83–99
  17. Svensson AI, Akesson P, Engel JA, Soderpalm B. Testosterone treatment induces behavioral disinhibition in adult male rats. Pharmacol. Biochem. Behav. 2003;75:481–490
  18. Daderman AM, Strindlund H, Wiklund N, Fredriksson S-O, Lidberg L. The importance of urine sample in persons intoxicated with flunitrazepam—legal issues in a forensic psychiatric case study of a serial murderer. Foren. Sci. Int. 2003;137:21–27
  19. Gambi F, Conti CM, Grimaldi MR, Giampietro L, De Bernardis B, Ferro FM. Flunitrazepam a benzodiazepine most used among drug abusers. Int. J. Immunopathol. Pharmacol. 1999;12:157–159
  20. Salvaggio J, Jacob C, Schmitt C, Orizet C, Ruel M, Lambert H. Abuse of flunitrazepam in opioid addicts. Ann. Med. Interne (Paris). 2000;151:6–9
  21. Gable R. Acute toxic effects of club drugs. J. Psychoact. Drugs. 2004;36:303–313
  22. Weir E. Drug-facilitated date rape. Cmaj. 2001;165:80
  23. Rickert VI, Wiemann CM, Berenson AB. Flunitrazepam: more than a date rape drug. J. Pediatr. Adolesc. Gynecol. 2000;13:37–42
  24. Druid H, Holmgren P, Ahlner J. Flunitrazepam: an evaluation of use, abuse and toxicity. Foren. Sci. Int. 2001;122:136–141
  25. Anglin D, Spears KL, Hutson HR. Flunitrazepam and its involvement in date or acquaintance rape. Acad. Emerg. Med. 1997;4:323–326
  26. Bramness JG, Skurtveit S, Mørland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend. 2003;43:39–45
  27. Bramness JG, Skurtveit S, Mørland J. Testing for benzodiazepine inebriation—relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur. J. Clin. Pharmacol. 2003;59:593–601
  28. Bramness JG, Skurtveit S, Morland J. Clinical impairment of benzodiazepines—relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend. 2002;68:131–141
  29. Bachs L, Skurtveit S, Mørland J. Codein and clinical impairment - an effect not mediated by morphine. Eur. J. Clin. Pharmacol. 2003;
  30. Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Mørland J. Screening for drugs in forensic blood samples using EMIT urine assays. Foren. Sci. Int. 1990;44:179–185
  31. Christophersen AS, Mørland J. Drugged driving, a review based on the experience in Norway. Drug Alcohol Depend. 1997;47:125–135
  32. Gjerde H, Dahlin E, Christophersen AS. Simultaneous determination of common benzodiazepines in blood using capillary gas chromatography. J. Pharm. Biomed. Anal. 1992;10:317–322
  33. A.S. Christophersen, M. Gulliksen, I. Hasvold, U. Johansen, R. Karinen, Å. Ripel, M. Krogh, Screening, confirmation and quantification of drugs of abuse in whole blood by LC–MS (ESI), in: Proceedings of the TIAFT 2001, Praha.
  34. Beylich KM, Christophersen AS, Skurtveit S, Bjørneboe A, Mørland J. Frequency of different drugs in samples from Norwegian drivers suspected for impaired driving. Nor. J. Epidemiol. 1996;6:157–160
  35. Vollenweider FX, Gamma A, Liechti M, Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology. 1998;19:241–251
  36. Skurtveit S, Christophersen AS, Beylich KM, Bjørneboe A, Mørland J. Study of rearrests for drunken driving in Norway. Foren. Sci. Int. 1998;92:21–28
  37. Skurtveit S, Christophersen AS, Grung M, Morland J. Increased mortality among previously apprehended drunken and drugged drivers. Drug Alcohol Depend. 2002;68:143–150
  38. Covi L, Lipman LS. Diazepam induced hostility in depression. In: Proceedings of the American Psychiatric Association Scientific Meeting. Toronto, Canada. 1977;
  39. Gardner DL, Cowdry RW. Alprazolam-induced dyscontrol in borderline personality disorder. Am. J. Psychiatry. 1985;142:98–100
  40. Skurtveit S, Abotnes B, Christophersen AS. Drugged drivers in Norway with benzodiazepine detections. Foren. Sci. Int. 2002;125:75–82
  41. Hausken A, Skurtveit S, Christophersen A. Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs. Drug Alcohol Depend. 2006;79:423–429
  42. Barkley RA, Koplowitz S, Anderson T, McMurray MB. Sense of time in children with ADHD: effects of duration, distraction, and stimulant medication. J. Int. Neuropsychol. Soc. 1997;3:359–369

PII: S0379-0738(05)00392-0

doi: 10.1016/j.forsciint.2005.06.009

Forensic Science International
Volume 159, Issue 2 , Pages 83-91 , 2 June 2006

Article Tools

* Image Usage & Resolution